store at low temperature
store at -20°C
Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 222.00 | |
5 mg | In stock | $ 587.00 | |
10 mg | In stock | $ 943.00 | |
25 mg | In stock | $ 1,380.00 | |
50 mg | In stock | $ 1,880.00 | |
100 mg | In stock | $ 2,530.00 |
Description | Girentuximab (G250) is a potent anti-carbonic anhydrase IX (CAIX) monoclonal antibody with anticancer activity for the study of uroepithelial carcinoma PET (ZiPUP). |
In vitro | Girentuximab is a chimeric version of a mouse monoclonal antibody (mAb) with IgG1 κ light chain and is capable of recognizing the CAIX antigen [1]. |
Synonyms | cG250, WX-G250, G250 |
Molecular Weight | N/A |
CAS No. | 916138-87-9 |
store at low temperature
store at -20°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Girentuximab 916138-87-9 Metabolism Carbonic Anhydrase cG250 WX-G250 G250 inhibitor inhibit